A new catheter to treat ventricular tachycardia
Eliminating Ventricular Tachycardia: Pivotal Clinical Trial using the Durablate® Catheter
['FUNDING_SBIR_2'] · THERMEDICAL, INC. · NIH-10928202
This study is testing a new catheter called Durablate® that aims to help people with ventricular tachycardia (VT) by using heat and special imaging to treat the heart more effectively and gently than current options.
Quick facts
| Phase | ['FUNDING_SBIR_2'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | THERMEDICAL, INC. (nih funded) |
| Locations | 1 site (WALTHAM, UNITED STATES) |
| Trial ID | NIH-10928202 on ClinicalTrials.gov |
What this research studies
This research focuses on developing the Durablate® Catheter, a novel tool designed to treat ventricular tachycardia (VT), a serious heart condition that can lead to sudden cardiac death. The study aims to improve upon existing treatments, such as implantable cardioverter defibrillators (ICDs), which are costly and not curative. By utilizing advanced imaging techniques and a unique method of delivering heated saline with radiofrequency energy, the catheter targets and ablates the heart tissue responsible for VT. This approach seeks to provide a more effective and less traumatic solution for patients suffering from this condition.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with ventricular tachycardia who may benefit from a more effective treatment option.
Not a fit: Patients with other types of arrhythmias or those who do not have ventricular tachycardia may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the need for expensive ICDs and improve the quality of life for patients with ventricular tachycardia.
How similar studies have performed: Previous research has shown promise in using ablation techniques for treating arrhythmias, but this specific approach with the Durablate® Catheter is novel.
Where this research is happening
WALTHAM, UNITED STATES
- THERMEDICAL, INC. — WALTHAM, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: CURLEY, MICHAEL G — THERMEDICAL, INC.
- Study coordinator: CURLEY, MICHAEL G
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.